Hemostasis Today

April, 2026
April 2026
M T W T F S S
 12345
6789101112
13141516171819
20212223242526
27282930  
Meghanath Yenni: Key Takeaways From Updated NICE Blood Transfusion Guideline
Apr 17, 2026, 15:42

Meghanath Yenni: Key Takeaways From Updated NICE Blood Transfusion Guideline

Meghanath Yenni, Consultant Physician at Medicover Hospitals, shared a post on LinkedIn:

Blood Transfusion: NICE Guideline (NG24, Updated 2026):

1. Core Principle:

  • Use blood only when clearly indicated
  • Prefer restrictive strategies

Always:

  • Assess clinical status with labs
  • Reassess after each unit/component

Aim:

Minimize unnecessary transfusions

2. Red Blood Cell (RBC) Transfusion

  • Thresholds (Most Important Clinical Takeaway)
    Stable patients (no ACS, no major bleed):Hb trigger: ≤7 g/dL/ Target: 7–9 g/dL
    Acute Coronary Syndrome (ACS):Hb trigger: ≤8 g/dL/ Target: 8–10 g/dL
  • Dosing Strategy: Give 1 unit at a time
    Reassess clinically and Hb before next unit

This is critical to avoid over-transfusion

3. Platelet Transfusion

  • When Bleeding
    Platelets less than 30,000: Transfuse
    Severe bleeding / CNS bleed: target up to 100,000
  • Prophylaxis (No bleeding)
    Lesser than 10,000: Transfuse
  • Procedures
    General surgery: greater than 50,000
    High-risk / CNS: greater than 100,000

Avoid Prophylaxis in: ITP HIT TTP
Chronic marrow failure (routine use not advised)

4. Fresh Frozen Plasma (FFP)

Indications

Active bleeding with INR/APTT greater than 1.5

Do NOT use:

  • For abnormal INR without bleeding
  • For warfarin reversal (use PCC instead)

Procedures

Consider if there is abnormal coagulation with bleeding risk

5. Cryoprecipitate

Indications

Bleeding with fibrinogen less than 1.5 g/L

Surgery:

If fibrinogen is less than 1.0 g/L, give prophylactically

Avoid:

If not bleeding and no procedure

6. Prothrombin Complex Concentrate (PCC)

Emergency Use

  • Warfarin reversal in Severe bleeding
  • Head injury with suspected ICH
  • Monitor INR and repeat if needed

7. Tranexamic Acid (MAJOR 2026 UPDATE)

Practice-Changing Recommendation

Give TXA to ALL surgical patients if:

  • Any bleeding risk
  • Skin/mucosa breached

Dose:

Adults: 1 g IV before surgery

Benefits:

  • Reduced Transfusion need
  • Reduced Hospital stay
  • Reduced Infection, bleeding

Caution:

Renal impairment with accumulation risk
Avoid wrong route (fatal if intrathecal)

8. Reducing Need for Transfusion (Prevention Strategy)

Before Surgery

  • Oral iron is first line
  • IV iron is used if there is Intolerance, Short time to surgery
  • Erythropoietin is not routine

Intra-op:

TXA with consideration of cell salvage for major blood loss

9. Safety and Monitoring

  • Mandatory: Monitor Vitals before, during, after
  • Watch for: Acute transfusion reactions
  • System-level: Use electronic ID systems to reduce errors

10. Clinical ‘Rules of Thumb’:

  • ‘7 is safe’ means Hb 7 g/dL in stable patients
  • ‘One unit than reassess’
  • Platelets:
    10k (no bleed), 30k (bleed), 50k (surgery), 100k (CNS)
  • FFP only if bleeding and INR greater than 1.5
  • Cryo if fibrinogen less than 1.5 and bleeding
  • PCC equals warfarin emergency reversal
  • TXA now routine in surgery

Source:
NICE Blood Transfusion Guideline (NG24, Updated February 2026)”

Meghanath Yenni

Stay updated on all scientific advances with Hemostasis Today.